UNIGE document Scientific Article
previous document  unige:87955  next document
add to browser collection
Title

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

Authors
McInnes, Iain B
Kavanaugh, Arthur
Tuckwell, Katie
Klearman, Micki
Pulley, Jennifer
Sattar, Naveed
Published in Annals of the Rheumatic Diseases. 2016, vol. 75, no. 10, p. 1806-1812
Abstract Compare changes in lipids and lipid-associated cardiovascular (CV) risk markers in patients with rheumatoid arthritis (RA) treated with tocilizumab or adalimumab.
Identifiers
PMID: 26613768
Full text
Article (Published version) (535 Kb) - public document Free access
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
GABAY, Cem et al. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. In: Annals of the Rheumatic Diseases, 2016, vol. 75, n° 10, p. 1806-1812. https://archive-ouverte.unige.ch/unige:87955

82 hits

29 downloads

Update

Deposited on : 2016-10-04

Export document
Format :
Citation style :